Multiple factors propel the Inhalation Preparation Market forward. The global burden of respiratory diseases is staggering—approximately 300 million people suffer from asthma, while COPD ranks as the third leading cause of death worldwide. This epidemiological reality creates relentless demand for effective inhalation therapies. Technological advancements in device design, including smart...

The Inhalation Preparation Market faces unique and complex challenges in generic development where demonstrating bioequivalence between innovator and generic inhaled products requires far more than the pharmacokinetic studies sufficient for oral medications. The device-formulation combination in inhalers means that seemingly minor changes in either component can significantly alter lung...